Resverlogix's apabetalone shows favorable PK profile in severe renal impairment Nov. 18, 2016 No Comments
Reata Pharmaceuticals announces plans to study bardoxolone methyl in new indication Nov. 15, 2016 No Comments
ChemoCentryx's CCX-168 leads to improvements in patient with C3 glomerulopathy Oct. 28, 2016 No Comments
Omeros reports phase II data for OMS-721, pursuing FDA breakthrough therapy designation Oct. 18, 2016 No Comments
Phase II results lead NeuroVive to discontinue development of CicloMulsion for acute kidney injury Oct. 13, 2016 No Comments
RSS